Memento Medicines
Developing biologic therapies for retinal diseases.
Developing biologic therapies for retinal diseases. Headquartered in Boston, MA. Raised $93M in Series A funding in June 2026 led by Forbion.
Biotechnology
📍 Boston, MA
Founded 2026
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Memento Medicines going public?
No. Memento Medicines is private and has not filed to go public. There is no S-1 on file.
What is Memento Medicines' valuation in 2026?
No confirmed valuation is on record for Memento Medicines. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Memento Medicines filed an S-1?
No public S-1 is on file for Memento Medicines.
Who are Memento Medicines' investors?
Memento Medicines' investors include Forbion, RA Capital Management, Avego BioScience Capital, Sanofi Ventures, Samsara BioCapital.
How much has Memento Medicines raised?
Memento Medicines has raised $93M in total across 1 disclosed round, most recently a Series A of $93M in Jun 2026.
Is Memento Medicines publicly traded — can you buy Memento Medicines stock?
No. Memento Medicines is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Memento Medicines on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Last Round
Series A — $93M (Jun 2026) · Lead: Forbion
Fundraising Status
Series A · $93M · 3 mo ago
privateTotal raised $93M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series A | $93M | Jun 2026 | Forbion | — |
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Memento Medicines — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-19. Re-checked weekly.
Talent Signal
No public careers page or job board could be found for Memento Medicines as of 2026-09-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
Investors
Forbion · RA Capital Management · Avego BioScience Capital · Sanofi Ventures · Samsara BioCapital
BiotechnologyBiologicsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.